Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002378 |
---|---|
Receipt number | R000002912 |
Scientific Title | Safety and efficacy of FOLFOX plus bevacizumab or FOLFIRI plus bevacizumab as second line Therapy in Advanced colorectal Cancer previously treated with bevacizumab. |
Date of disclosure of the study information | 2009/08/28 |
Last modified on | 2019/12/19 15:47:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/08/25 09:49:38 | ||
2 | Update | 2011/03/28 14:01:35 | Name of person sending information Organization Division name Address Organization2 Email2 |
|
3 | Update | 2011/09/28 09:33:43 | Recruitment status |
|
4 | Update | 2019/12/19 15:33:24 | UMIN ID1 |
|
5 | Update | 2019/12/19 15:44:43 | Recruitment status Date of IRB |
|
6 | Update | 2019/12/19 15:47:01 | UMIN ID2 |